Fund Holdings — Ikarian Capital, LLC

Total Portfolio Value:
$306.94M
Total Bought:
$127.38M
Total Sold:
$108.27M
Net Transaction:
+$19.11M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Tarsus Pharmaceuticals, Inc.(TARS)607,689485,021-122,668$33.65M$24.92M8.12%-$8.73M
Crinetics Pharmaceuticals In516,431523,431+7,000$26.41M$17.56M5.72%-$8.85M
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)025,000+25,000$0$13.98M4.56%+$13.98M
Sarepta Therapeutics, Inc.(SRPT)34,087169,087+135,000$4.14M$10.79M3.52%+$6.65M
Blueprint Medicines Corp169,374113,904-55,470$14.77M$10.08M3.28%-$4.69M
Akero Therapeutics Inc0245,000+245,000$0$9.92M3.23%+$9.92M
Alnylam Pharmaceuticals, Inc.(ALNY)031,594+31,594$0$8.53M2.78%+$8.53M
TG Therapeutics, Inc.(TGTX)291,240210,065-81,175$8.77M$8.28M2.70%-$483.5K
Verona Pharma PlcADS80,000130,000+50,000$3.72M$8.25M2.69%+$4.54M
Ultragenyx Pharmaceutical Inc.(RARE)178,989216,989+38,000$7.53M$7.86M2.56%+$327.1K
Scholar Rock Holding Corporation(SRRK)357,185244,179-113,006$15.44M$7.85M2.56%-$7.59M
Vaxcyte, Inc.(PCVX)0200,000+200,000$0$7.55M2.46%+$7.55M
Vir Biotechnology, Inc.(VIR)897,8621,068,062+170,200$6.59M$6.92M2.25%+$330.7K
Viridian Therapeutics, Inc.(VRDN)469,949494,949+25,000$9.01M$6.67M2.17%-$2.34M
Insmed Incorporated(INSM)119,80084,800-35,000$8.27M$6.47M2.11%-$1.80M
Edgewise Therapeutics, Inc.(EWTX)0280,000+280,000$0$6.16M2.01%+$6.16M
Catalyst Pharmaceuticals Inc349,649249,649-100,000$7.30M$6.05M1.97%-$1.24M
Cytokinetics, Incorporated(CYTK)149,982149,9820$7.06M$6.03M1.96%-$1.03M
Enliven Therapeutics Inc394,538289,538-105,000$8.88M$5.70M1.86%-$3.18M
Praxis Precision Medicines, Inc.(PRAX)0145,502+145,502$0$5.51M1.80%+$5.51M
Cidara Therapeutics Inc53,940248,940+195,000$1.45M$5.36M1.75%+$3.91M
Alpha Cognition Inc. Common Stock(ACOG)755,867967,867+212,000$4.45M$5.11M1.66%+$658.3K
Tectonic Therapeutic, Inc.(TECX)142,328269,090+126,762$6.57M$4.77M1.55%-$1.81M
Forte Biosciences Inc609,225609,2250$13.84M$4.73M1.54%-$9.11M
Structure Therapeutics IncADS284,085264,085-20,000$7.70M$4.57M1.49%-$3.13M
Metsera Inc0150,000+150,000$0$4.08M1.33%+$4.08M
Neuronetics, Inc.(STIM)01,100,000+1,100,000$0$4.05M1.32%+$4.05M
Dyne Therapeutics, Inc.(DYN)0358,837+358,837$0$3.75M1.22%+$3.75M
Trevi Therapeutics, Inc.(TRVI)325,000575,000+250,000$1.34M$3.62M1.18%+$2.28M
Maze Therapeutics, Inc.(MAZE)0322,740+322,740$0$3.55M1.16%+$3.55M
Janux Therapeutics, Inc.(JANX)74,691129,691+55,000$4.00M$3.50M1.14%-$497.3K
Eledon Pharmaceuticals, Inc.(ELDN)1,126,6371,025,221-101,416$4.64M$3.48M1.13%-$1.17M
BridgeBio Pharma, Inc.(BBIO)215,71390,837-124,876$5.92M$3.14M1.02%-$2.78M
Cumberland Pharmaceuticals Inc.(CPIX)0740,000+740,000$0$3.13M1.02%+$3.13M
Keros Therapeutics, Inc.(KROS)0274,009+274,009$0$2.79M0.91%+$2.79M
Abeona Therapeutics Inc.(ABEO)533,581533,5810$2.97M$2.54M0.83%-$432.2K
Helus Pharma Inc(HELP)397,175397,1750$3.50M$2.52M0.82%-$985.0K
iBio, Inc.CON NEW(IBIO)599,913599,9130$1.47M$2.41M0.79%+$941.9K
Bright Minds Biosciences Inc.(DRUG)152,21165,431-86,780$5.48M$2.36M0.77%-$3.12M
Evolus, Inc.(EOLS)373,265193,265-180,000$4.12M$2.32M0.76%-$1.80M
Relay Therapeutics, Inc.(RLAY)693,308743,308+50,000$2.86M$1.95M0.63%-$909.0K
Lexeo Therapeutics, Inc.(LXEO)499,301550,029+50,728$3.29M$1.91M0.62%-$1.38M
Arcturus Therapeutics Holdings Inc.(ARCT)200,000175,000-25,000$3.39M$1.85M0.60%-$1.54M
Kodiak Sciences Inc.(KOD)576,166649,534+73,368$5.73M$1.82M0.59%-$3.91M
Oruka Therapeutics, Inc.(ORKA)0175,000+175,000$0$1.80M0.58%+$1.80M
Apellis Pharmaceuticals Inc
COM
3,59475,000+71,406$114.7K$1.64M0.53%+$1.53M
Verve Therapeutics Inc169,991358,393+188,402$958.7K$1.64M0.53%+$679.1K
Arvinas, Inc.(ARVN)0229,900+229,900$0$1.61M0.53%+$1.61M
Avalo Therapeutics, Inc.(AVTX)970,259200,000-770,259$7.21M$1.60M0.52%-$5.61M
Vistagen Therapeutics, Inc.(VTGN)77,616601,703+524,087$229.0K$1.50M0.49%+$1.28M
Rocket Pharmaceuticals, Inc.(RCKT)221,911221,9110$2.79M$1.48M0.48%-$1.31M
Ventyx Biosciences Inc1,092,5901,217,590+125,000$2.39M$1.40M0.46%-$992.5K
Arcus Biosciences, Inc.(RCUS)378,363163,363-215,000$5.63M$1.28M0.42%-$4.35M
Delcath Systems, Inc.(DCTH)100,365100,3650$1.21M$1.28M0.42%+$69.3K
Sangamo Therapeutics, Inc.(SGMOQ)1,860,1791,860,1790$1.90M$1.22M0.40%-$677.5K
Viking Therapeutics, Inc.(VKTX)050,000+50,000$0$1.21M0.39%+$1.21M
Teladoc Health, Inc.(TDOC)0150,000+150,000$0$1.19M0.39%+$1.19M
Alector Inc950,000950,0000$1.80M$1.17M0.38%-$627.0K
OnKure Therapeutics, Inc.CL A(OKUR)253,754253,7540$2.18M$1.09M0.36%-$1.09M
Nuvation Bio Inc.CL A(NUVB)83,407619,258+535,851$221.9K$1.09M0.36%+$868.0K
Nektar Therapeutics(NKTR)2,029,0281,579,528-449,500$1.89M$1.07M0.35%-$812.9K
Tourmaline Bio Inc67,92767,9270$1.38M$1.03M0.34%-$344.4K
Immunic, Inc.(IMUX)1,614,170914,170-700,000$1.61M$996.4K0.32%-$617.7K
Terns Pharmaceuticals Inc308,491308,4910$1.71M$851.4K0.28%-$857.6K
Solid Biosciences Inc0230,000+230,000$0$851.0K0.28%+$851.0K
89bio Inc0100,000+100,000$0$727.0K0.24%+$727.0K
Olema Oncology, Inc.(OLMA)91,994191,994+100,000$536.3K$721.9K0.24%+$185.6K
Veru Inc.(VERU)945,2391,425,239+480,000$614.9K$698.5K0.23%+$83.6K
Lexicon Pharmaceuticals, Inc.(LXRX)1,550,0001,417,952-132,048$1.14M$653.4K0.21%-$491.3K
Monte Rosa Therapeutics, Inc.(GLUE)311,575136,575-175,000$2.16M$633.7K0.21%-$1.53M
Channel Therapeutics Corpora0440,849+440,849$0$626.0K0.20%+$626.0K
Pyxis Oncology, Inc.(PYXS)613,253613,2530$956.7K$600.9K0.20%-$355.7K
Inhibrx Biosciences, Inc.(INBX)42,12242,1220$648.7K$589.3K0.19%-$59.4K
Fulcrum Therapeutics, Inc.(FULC)200,096200,0960$940.5K$576.3K0.19%-$364.2K
Springworks Therapeutics Inc37,51912,519-25,000$1.36M$552.5K0.18%-$803.1K
Kezar Life Sciences Inc
COM NEW
106,901106,9010$718.4K$521.7K0.17%-$196.7K
Tessera Defense and Homeland Security Inc.(HLSQ)892,976892,9760$652.0K$496.2K0.16%-$155.7K
Lyell Immunopharma, Inc.(LYEL)1,276,037876,037-400,000$816.7K$471.3K0.15%-$345.4K
Iteos Therapeutics Inc78,58578,5850$603.5K$469.2K0.15%-$134.4K
Vigil Neuroscience Inc500,000250,000-250,000$850.0K$445.0K0.14%-$405.0K
Aethlon Med Inc750,0001,229,285+479,285$645.0K$440.1K0.14%-$204.9K
Alto Neuroscience, Inc.(ANRO)350,000175,000-175,000$1.48M$378.0K0.12%-$1.10M
Mind Medicine Mindmed Inc62,69162,6910$436.3K$366.7K0.12%-$69.6K
Third Harmonic Bio Inc100,000100,0000$1.03M$347.0K0.11%-$682.0K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)058,300+58,300$0$332.3K0.11%+$332.3K
Tyra Biosciences, Inc.(TYRA)60,00035,000-25,000$834.0K$325.5K0.11%-$508.5K
Acumen Pharmaceuticals, Inc.(ABOS)265,769265,7690$457.1K$292.3K0.10%-$164.8K
Cartesian Therapeutics, Inc.(RNAC)52,16622,166-30,000$934.3K$292.1K0.10%-$642.1K
Spruce Biosciences Inc1,000,0001,000,0000$420.0K$290.1K0.09%-$129.9K
Allakos Inc971,9501,171,950+200,000$1.18M$266.7K0.09%-$909.3K
Geron Corporation(GERN)0150,000+150,000$0$238.5K0.08%+$238.5K
Chemomab Therapeutics LtdADS213,052213,0520$385.6K$232.2K0.08%-$153.4K
Aclaris Therapeutics, Inc.(ACRS)350,000150,900-199,100$868.0K$230.9K0.08%-$637.1K
Monopar Therapeutics Inc.(MNPR)5,9085,9080$130.0K$215.1K0.07%+$85.1K
Climb Bio, Inc.(CLYM)175,088175,0880$315.2K$213.6K0.07%-$101.6K
PepGen Inc.(PEPG)0150,000+150,000$0$210.8K0.07%+$210.8K
Anebulo Pharmaceuticals Inc157,720157,7200$265.0K$205.0K0.07%-$59.9K
Voyager Therapeutics, Inc.(VYGR)55,76655,7660$316.2K$188.5K0.06%-$127.7K
Elevation Oncology Inc690,050690,0500$388.2K$178.8K0.06%-$209.4K
Faeth Therapeutics, Inc.(FTH)649,963449,963-200,000$318.5K$177.3K0.06%-$141.3K
Page 1 of 2
Ikarian Capital, LLC — 13F Holdings — Q1 2025 | TickerTrail